CFTR and cystic fibrosis: Currently, there is no specific therapy for CF-related pancreatitis, but new and highly effective CFTR modulator therapies aiming to modulate and potentiate the CFTR function may have implications for specific mutations affecting the gastrointestinal component of patients with CF-related pancreatitis and EPI [24,25].